Consistently, many research studies showed that targeting SCD1 activity is sufficient to attenuate obesity related chronic diseases, indicating that modulation of SCD1 activity may confer many beneficial health outcomes. The gene discussed is SCD; the disease is obesity due to melanocortin 4 receptor deficiency.